Dyslipidemia News

"Epidemiology: Dyslipidemia - Undertreated and Underdiagnosed Pandemic" - New ... - SBWire (press release)



"Epidemiology: Dyslipidemia - Undertreated and Underdiagnosed Pandemic" - New ... 
SBWire (press release)
Williamstown, MA -- (SBWIRE) -- 05/10/2012 -- The large numbers of adults with dyslipidemia in the seven major markets can be directly attributed to lifestyle choices, such as high caloric intake and limited physical activity.

 


JAPAN TOBACCO : Termination of all the studies of anti-dyslipidemia drug JTT ... - 4-traders



JAPAN TOBACCO : Termination of all the studies of anti-dyslipidemia drug JTT ... 
4-traders
Termination of all the studies of anti-dyslipidemia drug JTT-705 (dalcetrapib), JT's partner, F. Hoffmann-La Roche Ltd., has announced Japan Tobacco Inc. (JT) (TSE: 2914) today announced that F. Hoffmann-La Roche Ltd. (Roche) issued a press release on ...

and more » 


Cardiologists Urged to Lead in Smoking Cessation - MedPage Today



Cardiologists Urged to Lead in Smoking Cessation 
MedPage Today
Cardiologists as a group have largely ignored tobacco as a modifiable risk factor, concentrating instead on hypertension and dyslipidemia. In one program, the "Ottawa Model for Smoking Cessation," they boast a 35% to 50% absolute cessation rate and ...
Present-day efforts to aid quit-smoking attempts are substandard, says expert TheHeart.Org

all 2 news articles » 


New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk ... - MarketWatch (press release)



New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk ... 
MarketWatch (press release)
These abnormalities, commonly referred to as "dyslipidemia," are a major risk factor for coronary artery disease," said Brian E. Ward, Ph.D., Chief Executive Officer of diaDexus. "As more health care professionals utilize Lp-PLA2 as a component of ...

and more » 


ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched ... - MarketWatch (press release)



ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched ... 
MarketWatch (press release)
The randomized, double-blind placebo-controlled study evaluated pTeroPure® effects on blood pressure, total triglycerides, cholesterol, as well as improve markers for oxidative stress in patients with dyslipidemia-meeting inclusion criteria.

and more » 


Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 ... - MarketWatch (press release)



Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 ... 
MarketWatch (press release)
We look forward to the results from this study, expected in July 2012, to further validate the progression of Epanova as a best-in-class therapy for the treatment of patients with mixed dyslipidemia." Epanova is a patent protected, novel, ...

and more » 


New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk ... - PR Newswire (press release)



New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk ... 
PR Newswire (press release)
These abnormalities, commonly referred to as "dyslipidemia," are a major risk factor for coronary artery disease," said Brian E. Ward, Ph.D., Chief Executive Officer of diaDexus. "As more health care professionals utilize Lp-PLA2 as a component of ...

and more » 


Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 ... - PR Newswire (press release)



Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 ... 
PR Newswire (press release)
We look forward to the results from this study, expected in July 2012, to further validate the progression of Epanova as a best-in-class therapy for the treatment of patients with mixed dyslipidemia." Epanova is a patent protected, novel, ...

and more » 


Treatment of chronic hemodialysis patients with low-dose fenofibrate ... - 7thSpace Interactive (press release)



Treatment of chronic hemodialysis patients with low-dose fenofibrate ... 
7thSpace Interactive (press release)
Dyslipidemia is common in chronic hemodialysis patients and its underlying mechanism is complex. Hemodialysis causes an imbalance between antioxidants and production of reactive oxygen species, which induces the oxidative stress and thereby may lead to ...

 


Post-PCI Bleeds Drop with Shifts in Drug Strategy - MedPage Today



MedPage Today 
Post-PCI Bleeds Drop with Shifts in Drug Strategy 
MedPage Today
STEMI patients also were less likely to have cerebrovascular and peripheral vascular disease, hypertension, and dyslipidemia, and were younger than patients in the other two groups. Body mass index was similar among the three groups, as were family ...